In fact, DCs appear more efficient in cross-priming antigens carried by MVs than the soluble antigens (11, 32) and only when carried by MVs, large tumor glycosylated antigens as MUC1 are cross-presented and CD8+ T cell responses are activated (16). Here, CD8A is linked to neoplasm.